FREQUENT ORAL MUCOSA FINDINGS IN HIV INFECTED INDIVIDUALS

Abstract

Accuired Immune Deficiency Syndrome (AIDS) is first defined in 1981 and is being spread widely all over the world during recent years. Oral manifestations are the earliest and most important indicators of HIV infection. It is stil unclear why oral mucosal findings were the initial indicators of the HIV infection. Oral candidiasis, hairy leukoplakia, Kaposi sarcoma, ulcerations, herpes simplex, papilloma and periodontal diseases are strongly associated with HIV(+) patients respectively. Updated information about oral mucosa lesions associated with HIV(+) patients presented in this review.

Keywords

• -

HIV İLE ENFEKTE KİŞİLERDE SIKLIKLA GÖZLENEN ORAL MUKOZA BULGULARI

Abstract

Acquired Immuno Deficiency Syndrome (AIDS) ilk kez 1981 yılında tanımlanmış olup, son yıllarda hızla tüm dünyaya yayılmıştır. Human Immunodeficiency Virus (HIV) ile enfekte hastalarda ağız bulguları ilk ortaya çıkan ve en önemli olan bulgulardır. HIV enfeksiyonunda, oral mukoza lezyonlarının en önce ortaya çıkan bulgular olması henüz bir sebebe bağlanamamıştır. Bu hastalarda sıklık sırasına göre kandidiyazis, kıllı lökoplaki, kaposi sarkomu, ülserasyonlar, herpes simplaks, papilloma ve periodontal hastalıklar izlenmektedir. Bu derlemede HIV ile enfekte hastalarda gözlenen oral mukoza bulguları ile ilgili güncel bilgiler sunulmuştur. Abstract Accuired Immune Deficiency Syndrome (AIDS) is first defined in 1981 and is being spread widely all over the world during recent years. Oral manifestations are the earliest and most important indicators of HIV infection. It is stil unclear why oral mucosal findings were the initial indicators of the HIV infection. Oral candidiasis, hairy leukoplakia, Kaposi sarcoma, ulcerations, herpes simplex, papilloma and periodontal diseases are strongly associated with HIV(+) patients respectively. Updated information about oral mucosa lesions associated with HIV(+) patients presented in this review.

Keywords

• HIV, AIDS, oral mukoza

References

1. Fine DH, Tofsky N, Nelson EM, Schoen D, Barasch A. Clinical implications of the oral manifestations of HIV infection in children. Dental Clinics of North America 2003; 47(1):159-74.
2. Erbağcı Z. HIV Enfeksiyonunda Dermatolojik Bulgular. Türkiye Klinikleri Journal of Dermatoloji 1999; 9:95-103
3. Mosca NG, Rose Hathorn A. HIV- positive patients: dental management considerations.
4. America 2006; 50(4):635-57.
5. Bozkaya S, Karaca İ. İnsan İmmun Yetmezlik Virüsü Enfeksiyonları: Genel ve Ağız Bulguları. Cumhuriyet Üniversitesi Diş Hekimliği Fakültesi Dergisi 1998; 1(1): 48-55.
6. Olaniyi OT, Zuwaira H. The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria. Taiwo and Hassan AIDS Research and Therapy 2010; 7: 19.
7. Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson DE. Management of Oral Lesions in HIV- positive Patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics 2007; 103(1): 50.
8. Kannan R, Elumalaı G, Umadevı KMR, Kaazhıyur MV, Nagalıngeswaran K, Suniti S. Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India. International Journal of Paediatric Dentistry 2010; 20: 276–282.

9. Coogan MM, Greenspan J, Challacombe SJ. Oral lesions in infection with human immunodeŞciency virus. Bulletin of the World Health Organization 2005; 83:700- 706.
10. Vultaggio A, Lombardelli L, Giudizi MG, Biagiotti R, Mazzinghi B, Scaletti C, Mazzetti
11. Romagnani S, Maggi E, Piccinni MP. T cells speciŞc for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis. Microbes and Infection 2008; 10: 166-174.
12. Migliorati CA, Birman EG ve Cury AE. Oropharyngeal candidiasis in HIV- infected patients under treatment with protease inhibitors. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics 2004;98:301-10.
13. Mofenson LM, Oleske J, Serchuck L, Dyke RV ve Wilfert C. Treating Opportunistic Infections among HIV- Exposed
14. Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clinical Infectious Diseases 2005; 40:1–84.
15. Serdaroğlu S, Banıtahmaseb EK. AIDS ve Deri Bulguları. Dermatose 2003; 2: 107-116. C, Leoncini F, and Infected
16. Children: 13. Chattopadhyay A, Caplan DJ, Slade GD, Shugars DC, Tien HC ve Patton LL. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dentistry and Oral Epidemiology 2005; 33:35–44.
17. Tekeli A, Koyuncu E, Dolapçı I, Güven GS, Şahin GO ve Uzun O. Detection of Candida dubliniensis in oropharengeal samples of Turkish HIV- positive patients. Mycoses 2005; 48: 197- 201. 15.
18. Mshvidobadze K, Lomtadze M, Kandelaki G. Oral lesions in HIV-positive patients in Georgia. Georgian Medical News 2008; 165: 60-5.
19. Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. Journal of Oral Pathology&Medicine 2000; 29:336-41.
20. Greenspan D, Komaroff E, Redford M, Phelan JA, Navazesh M, Alves MEAF, Kamrath H, Mulligan R, Barr CE ve Greenspan JS. Oral Mucosal Lesions and HIV Viral Load in the Women’s Interagency HIV Study (WIHS). Journal of Acquired Immune Deficiency Syndromes 2000; 25:44–50.
21. Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves MEAF, MacPhail LA, Mulligan R ve Greenspan JS. Incidence of Oral Lesions in HIV-1-infected Women: Reduction with HAART. Journal of Dental Research 2004; 83(2):145-150.
22. Xin Wang, Xing Wang, Deguang Liang, Ke L, Wei G, Guoxin R. Classic Kaposi’s sarcoma in Han Chinese and useful tools for differential diagnosis. Oral Oncology 2010 46: 654–656.
23. Shetty K. Management of oral Kaposi’s sarcoma lesions on HIV-positive Patient using highly active antiretroviral theraphy: Case report and a rewiew of the literature. Oral Oncology Extra 2005; 41: 226-229.
24. Kathryn MC, Gcina M, Sarah S, Nathan PF, Andrew B, Gilles VC. AIDS- associated Kaposi’s sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa. Journal of the International AIDS Society 2010, 13: 23.
25. Webster-Cyriaque J, Duus K, Cooper C, Duncan M. Oral EBV and KSHV infection in HIV.
26. Research 2006; 19(1):91-5.
27. Androphy EJ, Lowy DR 196. Warts. In: W Klaus, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick’s Dermatology in General Medicine (7th ed), United States of America, McGraw-Hill Companies, 2008; 1914-1922.
28. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. The Lancet 2001; 357: 1411–12. Advances in Dental